先进的糖化最终产品,血清卡诺酶-1和糖尿病病和糖尿病视网膜病变之间的关系
1Tianjin Eye Hospital, Department of Clinical Laboratory, Tianjin, China.
Journal of medical biochemistry
|March 9, 2026
概括
在2型糖尿病患者中,高级糖化最终产品 (AGEs) 和肉酶-1 (CN-1) 的血清水平升高,并与糖尿病病 (DN) 和糖尿病视网膜病变 (DR) 有关. 这些标记物可能有助于诊断和治疗这些糖尿病并发症.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 眼科医生 眼科 眼科
背景情况:
- 2型糖尿病 (DM2) 是一种复杂的代谢障碍.
- 糖尿病病 (DN) 和糖尿病视网膜病 (DR) 是DM2.0的严重微血管并发症.
- 确定DN和DR的可靠生物标志物对于早期诊断和管理至关重要.
研究的目的:
- 调查高级糖化最终产品 (AGEs) 和肉酶-1 (CN-1) 的血清水平与2型糖尿病 (DM2) 患者糖尿病脏病 (DN) 和糖尿病视网膜病 (DR) 的存在之间的关联.
- 确定AGE和CN-1是否可以作为这些糖尿病微血管并发症的潜在诊断或预后指标.
主要方法:
- 一组150名患有2型糖尿病 (DM2) 的患者被根据DN和DR的存在或不存在划分为组.
- 采集了禁食静脉血液样本,以测量AGEs和CN-1的血清水平.
- 使用统计分析,包括皮尔森的相关性和多变量逻辑回归,来评估AGE,CN-1,DN和DR之间的关系.
主要成果:
- 与没有DN的患者相比,DN患者的AGEs和CN-1血清水平显著更高.
- 同样,DR患者的血清AGE和CN-1水平明显增加,与非DR组相比.
- 发现血清AGE和CN-1水平与DN和DR的发生有积极的相关性,并被确定为这两种疾病的独立风险因素.
结论:
- 血清AGE和CN-1水平升高与2型糖尿病患者的糖尿病脏病和糖尿病视网膜病变有显著联系.
- AGEs和CN-1显示出作为糖尿病微血管并发症的诊断和管理的新生物标志物的潜力.
- 需要进行进一步的研究,以探索针对糖尿病并发症的背景下,针对AGE和CN-1的治疗影响.
更多相关视频
相关概念视频
01:25Chronic Kidney Disease I: Introduction
928
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
928
01:30Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
01:28Chronic Kidney Disease III: Interprofessional Care
563
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
563
01:24Nephrotic Syndrome I : Introduction
790
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
790
01:19Overview of Carbohydrate Metabolism
4.0K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.0K
01:24Serum Studies: Renal Function Tests
564
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
564